Literature DB >> 6255223

Control of vascular responsiveness during human pregnancy.

N F Gant, R J Worley, R B Everett, P C MacDonald.   

Abstract

Normal human pregnancy is characterized by vascular refractoriness to AII. This pregnancy-induced vascular refractoriness appears to be mediated principally by decreased vascular smooth muscle responsiveness to AII rather than by alterations in blood volume or plasma concentrations of renin or AII. The mechanism that controls vascular refractoriness during normal pregnancy likely involves a localized prostaglandin or prostaglandin-like action mediated through cyclic nucleotides. The action of progesterone or one of its metabolites appears to mediate the synthesis or the catabolism of locally produced prostaglandins or prostaglandin-like agents.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6255223     DOI: 10.1038/ki.1980.133

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  26 in total

Review 1.  Preeclampsia and hypertensive disease in pregnancy: their contributions to cardiovascular risk.

Authors:  Carolina Valdiviezo; Vesna D Garovic; Pamela Ouyang
Journal:  Clin Cardiol       Date:  2012-03       Impact factor: 2.882

Review 2.  Gap junction regulation of vascular tone: implications of modulatory intercellular communication during gestation.

Authors:  Bryan C Ampey; Timothy J Morschauser; Paul D Lampe; Ronald R Magness
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

Review 3.  The 2010 Canadian Cardiovascular Society guidelines for the diagnosis and management of heart failure update: Heart failure in ethnic minority populations, heart failure and pregnancy, disease management, and quality improvement/assurance programs.

Authors:  Jonathan G Howlett; Robert S McKelvie; Jeannine Costigan; Anique Ducharme; Estrellita Estrella-Holder; Justin A Ezekowitz; Nadia Giannetti; Haissam Haddad; George A Heckman; Anthony M Herd; Debra Isaac; Simon Kouz; Kori Leblanc; Peter Liu; Elizabeth Mann; Gordon W Moe; Eileen O'Meara; Miroslav Rajda; Samuel Siu; Paul Stolee; Elizabeth Swiggum; Shelley Zeiroth
Journal:  Can J Cardiol       Date:  2010-04       Impact factor: 5.223

4.  The kidney in pregnancy: a review.

Authors:  J M Davison
Journal:  J R Soc Med       Date:  1983-06       Impact factor: 5.344

Review 5.  Renin-angiotensin system in pre-eclampsia: everything old is new again.

Authors:  Julia J Spaan; Mark A Brown
Journal:  Obstet Med       Date:  2012-12-06

Review 6.  Matrix metalloproteinases as drug targets in preeclampsia.

Authors:  Ana C T Palei; Joey P Granger; Jose E Tanus-Santos
Journal:  Curr Drug Targets       Date:  2013-03       Impact factor: 3.465

7.  Resistance artery adaptation to pregnancy counteracts the vasoconstricting influence of plasma from normal pregnant women.

Authors:  Odül A Amburgey; Shane A Reeves; Ira M Bernstein; Marilyn J Cipolla
Journal:  Reprod Sci       Date:  2009-09-18       Impact factor: 3.060

Review 8.  Hypertension in pregnancy. Pathophysiology and management.

Authors:  W F Lubbe
Journal:  Drugs       Date:  1984-08       Impact factor: 9.546

Review 9.  Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19, and the Renin-Angiotensin System: Pressing Needs and Best Research Practices.

Authors:  Matthew A Sparks; Andrew M South; Andrew D Badley; Carissa M Baker-Smith; Daniel Batlle; Biykem Bozkurt; Roberto Cattaneo; Steven D Crowley; Louis J Dell'Italia; Andria L Ford; Kathy Griendling; Susan B Gurley; Scott E Kasner; Joseph A Murray; Karl A Nath; Marc A Pfeffer; Janani Rangaswami; W Robert Taylor; Vesna D Garovic
Journal:  Hypertension       Date:  2020-09-28       Impact factor: 10.190

Review 10.  The functional role of the renin-angiotensin system in pregnancy and preeclampsia.

Authors:  R A Irani; Y Xia
Journal:  Placenta       Date:  2008-08-08       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.